Extended! eBooks from the 'Springer Archives' only $/€/£ 8.99 each–save now!

Resistance to Targeted Anti-Cancer Therapeutics

Resistance to Ibritumomab in Lymphoma

Editors: Hosono, Makoto, Chatal, Jean-François (Eds.)

Free Preview
    • This book features chapters written by internationally known experts in the field
    • This book will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects and medical physics that deals with radiation dosimetry
    • This book will provide future prospects for overcoming resistance and enhancing the efficacy of Ibritumomab
おすすめポイントをすべて見る

書籍の購入

イーブック ¥13,727
価格の適用国: Japan (日本円価格は個人のお客様のみ有効) (小計)
  • ISBN 978-3-319-78238-6
  • ウォーターマーク付、 DRMフリー
  • ファイル形式: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
ハードカバー ¥17,159
価格の適用国: Japan (日本円価格は個人のお客様のみ有効) (小計)
  • ISBN 978-3-319-78237-9
  • Free shipping for individuals worldwide
  • Institutional customers should get in touch with their account manager
  • Covid-19 shipping restrictions
  • Usually ready to be dispatched within 3 to 5 business days, if in stock
ソフトカバー ¥17,159
価格の適用国: Japan (日本円価格は個人のお客様のみ有効) (小計)
  • ISBN 978-3-030-08652-7
  • Free shipping for individuals worldwide
  • Institutional customers should get in touch with their account manager
  • Covid-19 shipping restrictions
  • Usually ready to be dispatched within 3 to 5 business days, if in stock
この書籍について

This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.

著者について

Makoto Hosono, MD, PhD, is a Professor of Radiology and Nuclear Medicine, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Japan, and serves as a member of Committee 3, International Commission on Radiological Protection. 


Jean-François Chatal, MD, PhD, is an Emeritus Professor of Nuclear Medicine at the University of Nantes, France. He is one of the international leaders who developed radioimmunotherapy, that is, therapy using radiolabeled anti-tumor antibodies. He created and headed an INSERM  research laboratory and also initiated the installation of a cyclotron institute termed ARRONAX for the production of novel radionuclides for nuclear medicine.

Table of contents (10 chapters)

Table of contents (10 chapters)
  • Clinical Use and Efficacy of Ibritumomab in B Cell Lymphoma

    Pages 1-8

    Choi, Ilseung (et al.)

  • Biology and Pathology of B-Cell Lymphoma

    Pages 9-31

    Tatsumi, Yoichi

  • Resistance to Y-90 Ibritumomab Tiuxetan Therapy

    Pages 33-57

    Abe, Koichiro

  • Features of Ibritumomab as Radionuclide Therapy

    Pages 59-66

    Hosono, Makoto

  • Radiological Evaluation of Response and Resistance of Ibritumomab

    Pages 67-77

    Ishimori, Takayoshi (et al.)

書籍の購入

イーブック ¥13,727
価格の適用国: Japan (日本円価格は個人のお客様のみ有効) (小計)
  • ISBN 978-3-319-78238-6
  • ウォーターマーク付、 DRMフリー
  • ファイル形式: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
ハードカバー ¥17,159
価格の適用国: Japan (日本円価格は個人のお客様のみ有効) (小計)
  • ISBN 978-3-319-78237-9
  • Free shipping for individuals worldwide
  • Institutional customers should get in touch with their account manager
  • Covid-19 shipping restrictions
  • Usually ready to be dispatched within 3 to 5 business days, if in stock
ソフトカバー ¥17,159
価格の適用国: Japan (日本円価格は個人のお客様のみ有効) (小計)
  • ISBN 978-3-030-08652-7
  • Free shipping for individuals worldwide
  • Institutional customers should get in touch with their account manager
  • Covid-19 shipping restrictions
  • Usually ready to be dispatched within 3 to 5 business days, if in stock
Loading...

この書籍のサービス情報

あなたへのおすすめ

Loading...

書誌情報

Bibliographic Information
Book Title
Resistance to Ibritumomab in Lymphoma
Editors
  • Makoto Hosono
  • Jean-François Chatal
Series Title
Resistance to Targeted Anti-Cancer Therapeutics
Series Volume
18
Copyright
2018
Publisher
Springer International Publishing
Copyright Holder
Springer International Publishing AG, part of Springer Nature
イーブック ISBN
978-3-319-78238-6
DOI
10.1007/978-3-319-78238-6
ハードカバー ISBN
978-3-319-78237-9
ソフトカバー ISBN
978-3-030-08652-7
Series ISSN
2196-5501
Edition Number
1
Number of Pages
XIII, 158
Number of Illustrations
4 b/w illustrations, 14 illustrations in colour
Topics